home / stock / nrbo / nrbo news


NRBO News and Press, NeuroBo Pharmaceuticals Inc. From 09/29/22

Stock Information

Company Name: NeuroBo Pharmaceuticals Inc.
Stock Symbol: NRBO
Market: NASDAQ
Website: neurobopharma.com

Menu

NRBO NRBO Quote NRBO Short NRBO News NRBO Articles NRBO Message Board
Get NRBO Alerts

News, Short Squeeze, Breakout and More Instantly...

NRBO - NeuroBo Pharmaceuticals, Inc. Compliant with All Applicable Nasdaq Listing Criteria

NeuroBo Pharmaceuticals, Inc. Compliant with All Applicable Nasdaq Listing Criteria PR Newswire BOSTON , Sept. 29, 2022 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. ("NeuroBo") (Nasdaq: NRBO) today announced that on September 27, 2022 , NeuroBo recei...

NRBO - NRBO, FAZE: The Top 5 Short Squeeze Stocks to Watch This Week

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Alextype/Shutterstock.com Traders continue to show interest in short squeeze stocks this week as they seek out likely targets to push higher. This has us checking out Fintel’s Short Squeeze Leaderb...

NRBO - What Is Going on With HeartBeam (BEAT) Stock Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: shutterstock.com/Anastasia Zagoruyko HeartBeam (NASDAQ: BEAT ) stock is rocketing higher on Thursday as investors react to news of a new heart monitor patent . This new patent covers a 12-lead electro...

NRBO - Why Is NeuroBo (NRBO) Stock Up 47% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Bukhta Yurii / Shutterstock.com NeuroBo (NASDAQ: NRBO ) stock is rising higher on Thursday after the clinical-stage biotechnology company announced a new strategic partnership with Dong-A ST . Neuro...

NRBO - NeuroBo stock soars 35% on license deal with Dong-A for NASH, obesity drugs

Boston-based NeuroBo Pharmaceuticals' ( NASDAQ: NRBO ) stock rose ~35% on Sept. 15 after it signed an agreement to license its shareholder Dong-A's two cardiometabolic assets DA-1241 and DA-1726. DA-1241 is being developed to treat nonalcoholic steatohepatitis (NASH)...

NRBO - NeuroBo Pharmaceuticals, Inc. and Dong-A ST Co. Ltd. Announce Strategic Collaboration to License and Develop Portfolio of Dong-A's Cardio-Metabolic Therapies

NeuroBo Pharmaceuticals, Inc. and Dong-A ST Co. Ltd. Announce Strategic Collaboration to License and Develop Portfolio of Dong-A's Cardio-Metabolic Therapies PR Newswire Exclusive License Agreement to Develop and Commercialize Phase II Clinical Stage New Chemical Entit...

NRBO - Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: f11photo/Shutterstock.com It’s time for another dive into the biggest pre-market stock movers as we see why shares are moving Thursday morning! Moving stocks this morning is clinical trial data, propo...

NRBO - Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Eric Urquhart/Shutterstock.com We’re starting off Wednesday with an overview of the biggest pre-market stock movers and the news moving those shares! That includes earnings reports, reverse stock spli...

NRBO - What Is Going on With NeuroBo (NRBO) Stock Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Andrus Ciprian / Shutterstock.com NeuroBo Pharmaceuticals  (NASDAQ: NRBO ) stock is rocketing higher on Tuesday after the company underwent a reverse stock split  this morning. NRBO stock we...

NRBO - NeuroBo (NRBO) Stock Soars 125% on Reverse Stock Split News

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today’s price action in  NeuroBo  (NASDAQ: NRBO ) is quite remarkable, to say the least. While many stocks in the market are up today, few have seen triple-digit increases like this clinical-stage biote...

Previous 10 Next 10